简介:FromJuly7to17in2009,the1stSino-GermanInt’lSymposiumonacupuncture&moxibustionwasheldinChengdu.Thirtywell-knownexpertsfromChina,Germany,theUnitedStates,Switzerlandandothercountrieshadathoroughexchangeanddiscussiononacupunctureandmoxibustionclinicalresearchandfuturetrends.Themaincontentsofthemeetingaresummarizedasfollows
简介:OnNovember15,2015,theAwardCeremonyof'2015internationalphotocontestofTCMacupuncturemoxibustion'washeldinBeijing,ChinabyHeadquartersoftheWorldFederationofAcupuncturemoxibustionSocieties(WFAS),congratulatingthe5thanniversarycelebrationofsuccessfulapplicationforthelistofworldheritageof'TCMacupuncturemoxibustion'and'Worldacupuncture-moxibustionweek'seriesofactivitiesof
简介:Asthelargestinternationalstandardsdevelopmentorganization,theInternationalOrganizationforStandardization(ISO)providesastructurefordevelopinginternationalstandardsoverahugerangeofindustrysectorsandthesestandardsaregloballyrespectedandutilized.Moreover,throughmanyimportantprocessesincludingtheconsensusapproach,ISOstandardscanassistinputtingintoplaceinternationallyagreed
简介:WFASInternationalAcupunctureConferencewasheldfrom25to27September2015attheInternationalPlazaHotel,Toronto,Ontario,Canada.Thisconferencewasco-sponsoredbyWorldFederationofAcupunctureMoxibustionSocieties(WFAS)andChinaAcademyofChineseMedicalSciences(CACMS),organizedbytheChineseMedicineandAcupunctureAssociationofCanada(CMAAC),andsupportedbyChinaAssociationof
简介:ISO18746:2016TraditionalChineseMedicine–SterileintradermalacupunctureneedlesforsingleusehasbeenpublishedonAugust15,2016.(http://www.iso.org/iso/home/store/catalogue_tc/catalogue_detail.htm?csnumber=63263)ISO18746:2016specifiestherequirementsofsterileintradermalacupunctureneedleforsingleuseasa
简介:目的:探讨醒脑开窍针刺治疗脑梗死恢复期的远期疗效及安全性。方法:脑梗死恢复期患者234例,以SAS编码,随机分配到醒脑开窍针刺组和常规针刺组(简称醒脑组和常规组)。醒脑组116例,接受醒脑开窍针剌(每日1次,共4周)和西医常规治疗;常规组118例,接受常规针刺和西医常规治疗。随访6个月。主要指标:随访期末生存、治疗和复发情况。次要指标:随访期末神经功能评估,针刺过程中不良事件发生率。结果:6个月随访时醒脑组病死率(0.86%)、继续治疗率(36.21%)与常规组(1.69%、36.44%)差异无统计学意义(X^2=0.29,P=0.59;X^2=0.32,P=0.57),在降低复发率、改善神经功能方面醒脑组优于常规组(P〈0.01);两组均未出现严重不良反应。结论:醒脑开窍针刺是安全的,其远期疗效在降低复发率、改善神经功能方面优于常规针刺。
简介:目的:探讨经筋排刺法结合皮肤针对脑卒中后上肢偏瘫患者痉挛状态的影响。方法:将488例脑卒中后上肢痉挛患者按计算机随机法以1:1比例随机分为2组:经筋排刺法结合皮肤针疗法组(A组,244例)和西药组(B组,244例)。在必要康复治疗的基础上,A组给予经筋排刺法配合皮肤针疗法,取穴以五腧穴等特定穴位为主,其中手三阳经给予经筋排刺法,手三阴经采用七星针叩刺;B组给予常规西药治疗,采用脑复康注射液、脑蛋白水解物静脉滴注。2组患者均连续治疗3周后评定临床疗效,采用改良Asworth量表、Fud—Meyer上肢运动评分量表观察两组患者治疗前后上肢痉挛程度、运动功能。结果:Asworth评分方面,A组效果明显优于B组(3.04±1.29vs3.88±1.54,P〈0.05);Fugl-Meyer评分万面,A组效果亦明显优于B组(48.67±15.64vs42.96±14.72,P〈0.05);A组上肢关节运动状况缓解程度方面,眉关节内收缓解程度(90.5%)、前臂旋前缓解程度(70.7%)、肘关节屈曲缓解程度(73.1%)、腕关节屈曲缓解程度(80.9%)、手指屈曲缓解程度(88.1%)均优于B组(70.0%,60.O%,61.9%,57.4%,63.2%,均P〈0.05)。结论:经筋排刺法结合皮肤针能明显改善脑卒中后上肢痉挛患者的痉挛状态,临床疗效确切。